Bone reconstruction: Au nanocomposite bioglasses with antibacterial properties

International Journal of Artificial Organs

Volumn 34, Issue 9, 2011, Pages 920-928

  Grandi, Stefania ^a   Cassinelli, Valentina ^a   Bini, Marcella ^a   Saino, Enrica ^a,b   Mustarelli, Piercarlo ^a,b   Arciola, Carla Renata ^c   Imbriani, Marcello ^d   Visai, Livia ^a,b,d,e  

^a UNIVERSITY OF PAVIA   (Italy)

^b Center for Tissue Engineering CIT   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d IRCCS   (Italy)

^e International Center for Studies and Research in Biomedicine (ICB)   (Belgium)

Author keywords

Antibacterial activity; Bioglass; Gold nanoparticles; Sol gel

Indexed keywords

BONE; DOPING (ADDITIVES); ESCHERICHIA COLI; FIBER OPTIC SENSORS; METAL NANOPARTICLES; SOL-GEL PROCESS; SOL-GELS;

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL PROPERTIES; BIOGLASSES; BONE RECONSTRUCTION; CLINICAL APPLICATION; GLASS CHEMISTRY; LIVING BONE; SENSING AND IMAGING; SENSING APPLICATIONS; SOL'GEL;

GOLD NANOPARTICLES;

BIOGLASS; GLASS; GOLD NANOPARTICLE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BONE REMODELING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; ESCHERICHIA COLI; NONHUMAN; STAPHYLOCOCCUS AUREUS;

EID: 81355136167     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000059     Document Type: Article

References (36)

1. ®. J Mater Sci Mater Med. 2006;17(11):967-978. doi:10.1007/s10856-006-0432-z.
2. Rahaman MN, Day DE, Sonny Bal B, et al. Bioactive glass in tissue engineering. Acta Biomater. 2011;7(6):2355-2373. doi:10.1016/j.actbio.2011.03.016.
3. Vallet-Regí M, Ragel CV, Salinas AJ. Glasses with Medical Applications. Eur J Inorg Chem. 2003;2003(6):1029-1042. doi:10.1002/ejic.200390134.
4. Cerruti M, Magnacca G, Bolis V, Morterra C. Characterization of sol-gel bioglasses with the use of simple model systems: a surface-chemistry approach. J Mater Chem. 2003;13(6):1279-1286. doi:10.1039/b300961k.
5. Vallet-Regi M. Revisting ceramics for medical applications. Dalton Trans. 2006;5211-5220. doi:10.1039/b610219k
6. Bini M, Grandi S, Capsoni D, Mustarelli P, Saino E, Visai L. SiO 2 -P 2 O 5 -CaO Glasses and Glass-Ceramics with and without ZnO: Relationships among Composition, Microstructure, and Bioactivity. J Phys Chem C. 2009;113(20):8821-8828. doi:10.1021/jp810977w.
7. Lei B, Chen X, Wang Y, et al. Fabrication of porous bioactive glass particles by one step sintering. Mater Lett. 2010;64(21):2293-2295. doi:10.1016/j.matlet.2010.07.066.
8. Wright JD, Sommerdijk NA. Sol-Gel Materials: Chemistry and Applications. London: Taylor & Francis; 2001.
9. Izquierdo-Barba I, Arcos D, Sakamoto Y, Terasaki O, López-Noriega A, Vallet-Regí M. High-Performance Mesoporous Bioceramics Mimicking Bone Mineralization. Chem Mater. 2008;20(9):3191-3198. doi:10.1021/cm800172x.
10. Shapoff CA, Alexander DC, Clark AE. Clinical use of a bioactive glass particulate in the treatment of human osseous defects. Compend Contin Educ Dent. 1997;18(4):352-354.
11. Jorge LS, Chuerie AG, Rossit ARB. Osteomyelitis: a current challenge. Braz J Infect Dis. 2010; 14(3) 310-315.
12. Ragel CV, Vallet-Regi M. In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. J Biomed Mater Res. 2000;51(3):424-429. doi:10.1002/1097- 4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E
13. Arcos D, Ragel CV, Vallet-Regi M. Bioactivity in glass/PMMA composites used as drug delivery system. Biomaterials. 2001;22(7):701-708. doi:10.1016/S0142-9612(00)00233-7.
14. Arcos D, Peña J, Vallet-Regí M. Influence of a SiO 2 -CaO-P 2 O 5 Sol-Gel Glass on the Bioactivity and Controlled Release of Ceramic/Polymer/Antibiotic Mixed Materials. Chem Mater. 2003;15(21):4132-4138. doi:10.1021/cm031074n.
15. Meseguer-Olmo L, Ros-Nicolás MJ, Vicente-Ortega V, et al. A bioactive sol-gel glass implant for in vivo gentamicin release. Experimental model in Rabbit. J Orthop Res. 2006;24(3):454-460. doi:10.1002/jor.20064.
16. Vallet-Regí M, Colilla M, González B. Medical applications of organic-inorganic hybrid materials within the field of silicabased bioceramics. Chem Soc Rev. 2011;40(2):596-607. doi:10.1039/c0cs00025f.
17. Munukka E, Leppäranta O, Korkeamäki M, et al. Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med. 2008;19(1):27-32. doi:10.1007/s10856-007-3143-1.
18. Catauro M, Raucci MG, de Gaetano F, Marotta A. Antibacterial and bioactive silver-containing Na 2 O·CaO·2SiO 2 glass prepared by sol-gel method. J Mater Sci Mater Med. 2004;15(7):831-837. doi:10.1023/ B:JMSM.0000032825.51052.00.
19. Zhang Y, Peng H, Huang W, Zhou Y, Yan D. Facile preparation and characterization of highly antimicrobial colloid Ag or Au nanoparticles. J Colloid Interface Sci. 2008;325(2):371-376. doi:10.1016/j.jcis.2008.05.063.
20. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions onEscherichia coli andStaphylococcus aureus. J Biomed Mater Res. 2000;52(4):662-668. doi:10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3.
21. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3(1):95-101. doi:10.1016/j.nano.2006.12.001.
22. Greulich C, Kittler S, Epple M, Muhr G, Köller M. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg. 2009;394(3):495-502. doi:10.1007/ s00423-009-0472-1.
23. Wang Z, Ma L. Gold nanoparticle probes. Coord Chem Rev. 2009;253(11-12):1607-1618. doi:10.1016/j.ccr.2009.01.005.
24. Lusvardi G, Malavasi G, Aina V, et al. Bioactive Glasses Containing Au Nanoparticles. Effect of Calcination Temperature on Structure, Morphology, and Surface Properties. Langmuir. 2010;26(12):10303-10314. doi:10.1021/la100472p.
25. Aina V, Marchis T, Laurenti E, et al. Functionalization of Sol Gel Bioactive Glasses Carrying Au Nanoparticles: Selective Au Affinity for Amino and Thiol Ligand Groups. Langmuir. 2010;26(24):18600-18605. doi:10.1021/la1036647.
26. Turkevich J, Stevenson PC, Hillier JJ. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc. 1951;11:55-75. doi:10.1039/df9511100055.
27. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproducein vivo surface-structure changes in bioactive glass-ceramic A-W3. J Biomed Mater Res. 1990;24(6):721-734. doi:10.1002/jbm.820240607.
28. Petrini P, Arciola CR, Pezzali I, et al. Antibacterial activity of zinc modified titanium oxide surface. Int J Artif Organs. 2006;29:434-442.
29. Borah BJ, Yadav A, Dutta DK. Au°-Nanoparticles: Control Size and Morphology Stabilized by Tripodal Phosphine Based Ligands and Their Antimicrobial Activity. J Biomed Nanotechnol. 2011;7(1):152-153. doi:10.1166/ jbn.2011.1245.
30. Hernández-Sierra JF, Ruiz F, Cruz Pena DC, et al. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold. Nanomedicine. 2008;4(3):237-240. doi:10.1016/j.nano.2008.04.005.
31. Dror-Ehre A, Mamane H, Belenkova T, Markovich G, Adin A. Silver nanoparticle-E. coli colloidal interaction in water and effect on E. coli survival. J Colloid Interface Sci. 2009;339(2):521-526. doi:10.1016/j.jcis.2009.07.052.
32. Eby DM, Schaeublin NM, Farrington KE, Hussain SM, Johnson GR. Lysozyme catalyzes the formation of antimicrobial silver nanoparticles. ACS Nano. 2009;3(4):984-994. doi:10.1021/nn900079e.
33. Panácek A, Kolár M, Vecerová R, et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials. 2009;30(31):6333-6340. doi:10.1016/j.biomaterials. 2009.07.065.
34. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76-83. doi:10.1016/j.biotechadv.2008.09.002.
35. Chwalibog A, Chwalibog, Sawosz, et al. Visualization of interaction between inorganic nanoparticles and bacteria or fungi. Int J Nanomedicine. 2010;5:1085-1094. doi:10.2147/ IJN.S13532.
36. Selvakannan PR, Mandal S, Phadtare S, Pasricha R, Sastry M. Capping of Gold Nanoparticles by the Amino Acid Lysine Renders Them Water-Dispersible. Langmuir. 2003;19(8):3545-3549. doi:10.1021/la026906v.